Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$245M |
| 2 |
KeyCorp
KEY
|
+$199M |
| 3 |
RTX Corp
RTX
|
+$183M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$170M |
| 5 |
Ralph Lauren
RL
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$245M |
| 2 |
US Bancorp
USB
|
+$216M |
| 3 |
Apple
AAPL
|
+$207M |
| 4 |
Visa
V
|
+$188M |
| 5 |
Bank of America
BAC
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 44.36% |
| 2 | Financials | 9.66% |
| 3 | Consumer Discretionary | 8.08% |
| 4 | Energy | 7.72% |
| 5 | Technology | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5526
PUT
Penske Automotive Group
PAG
$13.4B
| $64K | ﹤0.01% |
1,500
-1,000
| -40% | -$38.3K |
2013 Q2
1 quarter
|
|
5527
PRA Group
PRAA
$710M
| $64K | ﹤0.01% |
1,067
-36,919
| -97% | -$1.98M |
2013 Q2
1 quarter
|
|
5528
CALL
WisdomTree
WT
$3.69B
| $64K | ﹤0.01% |
5,500
-8,700
| -61% | -$105K |
2013 Q2
1 quarter
|
|
|
ATCO
5529
DELISTED
Atlas Corp.
ATCO
| $64K | ﹤0.01% |
2,612
+855
| +49% | +$18.6K |
2013 Q2
1 quarter
|
|
|
TGA
5530
PUT
DELISTED
Transglobe Energy Corp
TGA
| $64K | ﹤0.01% |
8,200
+3,100
| +61% | +$21.1K |
2013 Q2
1 quarter
|
|
|
IRF
5531
CALL
DELISTED
INTL RECTIFIER CORP
IRF
| $64K | ﹤0.01% |
2,600
-4,900
| -65% | -$119K |
2013 Q2
1 quarter
|
|
5532
PUT
St. Joe Company
JOE
$3.72B
| $63K | ﹤0.01% |
3,200
-2,800
| -47% | -$59K |
2013 Q2
1 quarter
|
|
5533
NovaGold Resources
NG
$2.87B
| $63K | ﹤0.01% |
27,124
+21,897
| +419% | +$57.2K |
2013 Q2
1 quarter
|
|
5534
PUT
Newell Brands
NWL
$2.3B
| $63K | ﹤0.01% |
2,300
-4,300
| -65% | -$115K |
2013 Q2
1 quarter
|
|
5535
CALL
Onto Innovation
ONTO
$16.1B
| $63K | ﹤0.01% |
3,900
-300
| -7% | -$4.51K |
2013 Q2
1 quarter
|
|
5536
Rigel Pharmaceuticals
RIGL
$881M
| $63K | ﹤0.01% |
1,771
-3,013
| -63% | -$110K |
2013 Q2
1 quarter
|
|
5537
PUT
Republic Services
RSG
$64.2B
| $63K | ﹤0.01% |
1,900
-7,900
| -81% | -$269K |
2013 Q2
1 quarter
|
|
5538
CALL
Texas Roadhouse
TXRH
$10.2B
| $63K | ﹤0.01% |
2,400
-6,200
| -72% | -$156K |
2013 Q2
1 quarter
|
|
|
ACHN
5539
PUT
DELISTED
Achillion Pharmaceuticals
ACHN
| $63K | ﹤0.01% |
20,700
-10,000
| -33% | -$68.5K |
2013 Q2
1 quarter
|
|
|
RDEN
5540
PUT
DELISTED
ELIZABETH ARDEN INC
RDEN
| $63K | ﹤0.01% |
+1,700
| New | +$66.6K |
2013 Q3
0 quarters
|
|
|
ACTV
5541
PUT
DELISTED
Active Network Inc
ACTV
| $63K | ﹤0.01% |
4,400
-2,400
| -35% | -$23.1K |
2013 Q2
1 quarter
|
|
|
FBC
5542
PUT
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $63K | ﹤0.01% |
4,300
-6,200
| -59% | -$94K |
2013 Q2
1 quarter
|
|
|
BRW
5543
Saba Capital Income & Opportunities Fund
BRW
$309M
| $62K | ﹤0.01% |
+5,082
| New | +$62.1K |
2013 Q3
0 quarters
|
|
5544
China Automotive Systems
CAAS
$139M
| $62K | ﹤0.01% |
8,243
-5,637
| -41% | -$42.2K |
2013 Q2
1 quarter
|
|
|
CADE
5545
CALL
DELISTED
Cadence Bank
CADE
| $62K | ﹤0.01% |
3,100
-100
| -3% | -$1.96K |
2013 Q2
1 quarter
|
|
5546
Jakks Pacific
JAKK
$311M
| $62K | ﹤0.01% |
1,380
+1,048
| +316% | +$68K |
2013 Q2
1 quarter
|
|
|
MRC
5547
CALL
DELISTED
MRC Global
MRC
| $62K | ﹤0.01% |
+2,300
| New | +$61.3K |
2013 Q3
0 quarters
|
|
5548
PUT
Novavax
NVAX
$1.73B
| $62K | ﹤0.01% |
975
-290
| -23% | -$16.3K |
2013 Q2
1 quarter
|
|
|
ALBO
5549
PUT
DELISTED
Albireo Pharma Inc
ALBO
| $62K | ﹤0.01% |
660
+370
| +128% | +$48.2K |
2013 Q2
1 quarter
|
|
|
BGG
5550
CALL
DELISTED
Briggs & Stratton Corp.
BGG
| $62K | ﹤0.01% |
3,100
-600
| -16% | -$12.1K |
2013 Q2
1 quarter
|
|
Similar funds
Citadel Advisors's Q3 2013 Portfolio in Review
As of Q3 2013, Citadel Advisors held 7,215 positions worth $65.7B, up 13% from $58.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Citadel Advisors withdrew a net $4.68B in Q3 2013, closing 505 positions and reducing 3,074 holdings. Its most notable exit was NEWS CORPORATION CL-A, an estimated $166M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, up from 41% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citadel Advisors opened a new position in ELAN CORP ADS(RP1 ORD4IRISH PN worth $100M.
- Citadel Advisors's largest Q3 2013 buy was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M.
- Citadel Advisors added most to Philip Morris in Q3 2013, an estimated $245M increase.
- Citadel Advisors's biggest Q3 2013 reduction was Pfizer, cutting an estimated $245M.
- Citadel Advisors fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $166M.
- Citadel Advisors's ten largest holdings make up 12% of its $65.7B portfolio in Q3 2013.
- Citadel Advisors opened 734 new positions and closed 505 in Q3 2013.
- Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $65.7B.
Based on Citadel Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.